PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 5 days 7 hours 48 minutes
Donna H. Ryan, MD, FTOS -Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Go online to PeerView.com/XRQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS - Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Go online to PeerView.com/FQJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Jaffer A. Ajani, MD / Ian Chau, MD, FRCP - Gaining New Ground With Immunotherapy in the Management of Early and Advanced Gastrointestinal Cancers: Translating Progress Into Clinical Practice in Gastric, Esophageal, GEJ, and Colorectal Cancers
Go online to PeerView.com/SXS860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Ronan J. Kelly, MD, MBA / Siva Raja, MD, PhD, FACS - Immune Checkpoint Inhibitor Therapy for Locally Advanced and Early-Stage Esophageal/GEJ Cancer: The Latest Evidence and Implications for Thoracic Surgeons and the Multidisciplinary Care Team
Go online to PeerView.com/PSN860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Suresh S. Ramalingam, MD, FACP, FASCO / Arjun Balar, MD / Yelena Janjigian, MD - Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
Go online to PeerView.com/CYY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Evan J. Lipson, MD - Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
Go online to PeerView.com/GAQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Kurt A. Schalper, MD, PhD / Shanu Modi, MD - HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Go online to PeerView.com/FFU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD - At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
Go online to PeerView.com/DCZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Karl E. Anderson, MD - Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Go online to PeerView.com/HKY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.
Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC - New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
Go online to PeerView.com/URQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.